LYEL
Price
$12.15
Change
+$0.43 (+3.67%)
Updated
Sep 5 closing price
Capitalization
233.42M
SBMFF
Price
$0.99
Change
+$0.04 (+4.21%)
Updated
Aug 13 closing price
Capitalization
20.43B
Interact to see
Advertisement

LYEL vs SBMFF

Header iconLYEL vs SBMFF Comparison
Open Charts LYEL vs SBMFFBanner chart's image
Lyell Immunopharma
Price$12.15
Change+$0.43 (+3.67%)
Volume$18.41K
Capitalization233.42M
Sino Biopharmaceutical
Price$0.99
Change+$0.04 (+4.21%)
Volume$132
Capitalization20.43B
LYEL vs SBMFF Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. SBMFF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongBuy and SBMFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LYEL: $12.15 vs. SBMFF: $0.99)
Brand notoriety: LYEL and SBMFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 39% vs. SBMFF: 3%
Market capitalization -- LYEL: $233.42M vs. SBMFF: $20.43B
LYEL [@Biotechnology] is valued at $233.42M. SBMFF’s [@Biotechnology] market capitalization is $20.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileSBMFF’s FA Score has 2 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • SBMFF’s FA Score: 2 green, 3 red.
According to our system of comparison, SBMFF is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while SBMFF’s TA Score has 3 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 3 bearish.
  • SBMFF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, SBMFF is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а +9.66% price change this week, while SBMFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBMFF($20.4B) has a higher market cap than LYEL($233M). SBMFF YTD gains are higher at: 140.481 vs. LYEL (-5.078). SBMFF has higher annual earnings (EBITDA): 6.98B vs. LYEL (-199.95M). SBMFF has higher revenues than LYEL: SBMFF (26.2B) vs LYEL (60K).
LYELSBMFFLYEL / SBMFF
Capitalization233M20.4B1%
EBITDA-199.95M6.98B-3%
Gain YTD-5.078140.481-4%
P/E RatioN/A32.66-
Revenue60K26.2B0%
Total Cash277MN/A-
Total Debt46.6MN/A-
FUNDAMENTALS RATINGS
SBMFF: Fundamental Ratings
SBMFF
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELSBMFF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 24 days ago
48%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NXTE34.980.39
+1.14%
AXS Green Alpha ETF
FNDX25.890.22
+0.86%
Schwab Fundamental U.S. Large CompanyETF
DEUS58.090.49
+0.85%
Xtrackers Russell US Multifactor ETF
PBFR28.330.11
+0.39%
PGIM Laddered S&P 500 Buffer 20 ETF
HFRO6.170.01
+0.16%
Highland Opportunities and Income Fund

SBMFF and

Correlation & Price change

A.I.dvisor tells us that SBMFF and PSTV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBMFF and PSTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBMFF
1D Price
Change %
SBMFF100%
N/A
PSTV - SBMFF
22%
Poorly correlated
-2.22%
BCDA - SBMFF
21%
Poorly correlated
N/A
INKT - SBMFF
21%
Poorly correlated
-2.31%
ALZN - SBMFF
20%
Poorly correlated
-3.81%
LYEL - SBMFF
20%
Poorly correlated
+2.54%
More